Cargando…
CONTOUR Australia: Condition of Submental Fullness and Treatment Outcomes with Belkyra Registry
Submental fat (SMF) contributes to an aged or overweight appearance that may negatively impact an individual’s psychological well-being. Deoxycholic acid (ATX-101) is an injectable formulation of deoxycholic acid approved to treat SMF. The Condition of Submental Fullness and Treatment Outcomes Regis...
Autores principales: | Boxley, Sarah G., Lin, Frank, Lee See, Neville, St. Rose, Suzanne, Battucci, Simona, Simonyi, Susan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353711/ https://www.ncbi.nlm.nih.gov/pubmed/37469476 http://dx.doi.org/10.1097/GOX.0000000000005123 |
Ejemplares similares
-
Submental Area Treatment with ATX-101: Relationship of Mechanism of Action, Tissue Response, and Efficacy
por: Humphrey, Shannon, et al.
Publicado: (2022) -
Best Clinical Practices with ATX-101 for Submental Fat Reduction: Patient-related Factors and Physician Considerations
por: Teller, Craig F., et al.
Publicado: (2021) -
The Perception of the Ideal Body Contouring in Mexico
por: Pérez Chávez, Francisco, et al.
Publicado: (2020) -
Novel Expanded Safe Zone for Reduction of Submental Fullness with ATX-101 Injection
por: Shridharani, Sachin M., et al.
Publicado: (2019) -
A New Surgical Approach to Body Contouring
por: Flores González, Emmanuel Armando, et al.
Publicado: (2021)